The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere

Surgical Neurology

Volumn 52, Issue 4, 1999, Pages 371-379

  Keles, G Evren ^b   Anderson, Brad ^a   Berger, Mitchel S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AMERICAN HOSPITAL   (Turkey)

Author keywords

Extent of tumor resection; Glioblastoma multiforme; Survival; Time to tumor progression

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; GLIOBLASTOMA; HEMISPHERE; HUMAN; MAJOR CLINICAL STUDY; MALE; SURVIVAL TIME; TUMOR GROWTH; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DISEASE PROGRESSION; FEMALE; GLIOBLASTOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0032729320     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(99)00103-2     Document Type: Article

References (39)

1. Albert F.K., Forsting M., Sartor K., Adams H.P., Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma objective evaluation of residual tumor and its influence on regrowth and prognosis . Neurosurgery. 34:1994;45-60.
2. Ammirati M., Vick N., Liao Y., Ciric I., Mikhael M. Effect of extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery. 21:1987;201-206.
3. Andreou J., George A.E., Wise A., de Leon M., Kricheff I.I., Ransohoff J., Foo S.H. CT prognostic criteria of survival after malignant glioma surgery. AJNR. 4:1983;488-490.
4. Berger M.S., Ojemann G.A., Lettich E. Neurophysiologial monitoring during astrocytoma surgery. Rosenblum M.L. Neurosurgery Clinics of North America. Vol 1:1990;65-80 WB Saunders, Philadelphia.
5. Berger M.S., Ghatan S., Geyer J.R., Keles G.E., Ojemann G.A. Seizure outcome in children with hemispheric tumors and associated intractable epilepsy the role of tumor removal combined with seizure foci resection . Pediatr Neurosurg. 17:1992;185-191.
6. Berger M.S., Ojemann G.A. Intraoperative brain mapping techniques in neuro-oncology. Stereotact Funct Neurosurg. 58:1992;153-161.
7. Berger M.S., Deliganis A.V., Dobbins J., Keles G.E. The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer. 74:1994;1784-1791.
8. Breslow NE, Day NE. Statistical methods in cancer research. International Agency for Research on Cancer (IARC), Lyon: W. Davis, 1980.
9. Burger P.C. The anatomy of astrocytomas. Mayo Clin Proc. 62:1987;527-529.
10. Chang C.H., Horton J., Schoenfeld D., Salazar O., Perez-Tamayo R., Kramer S., Weinstein A., Nelson J.S., Tsukada Y. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer. 52:1983;997-1007.
11. Ciric I., Ammirati M., Vick N., Mikhael M. Supratentorial gliomas surgical considerations and immediate postoperative results. Gross total resection versus partial resection . Neurosurgery. 21:1987;21-26.
12. Coffey R.J., Lunsford L.D., Taylor F.H. Survival after stereotactic biopsy of malignant gliomas. Neurosurgery. 22:1988;465-473.
13. Davis L., Martin J., Goldstein S.L. A study of 211 patients with verified glioblastoma multiforme. J Neurosurg. 6:1949;33-44.
14. Duong D.H., Rostomily R.C., Haynor D.R., Keles G.E., Berger M.S. Measurement of tumor resection volumes from computerized images. Technical note. J Neurosurg. 77:1992;151-154.
15. Filipek P.A., Kennedy D.N., Caviness V.S. Jr. Volumetric analyses of central nervous system neoplasm based on MRI. Pediatr Neurol. 7:1991;347-351.
16. Frankel S.A., German W.J. Glioblastoma multiforme. Review of 219 cases with regard to natural history, pathology, diagnostic methods, and treatment. J Neurosurg. 15:1958;489-503.
17. Gehan E.A., Walker M.D. Prognostic factors for patients with brain tumors. Natl Canc Inst Monogr. 46:1977;189-195.
18. Gutin P.H., Leibel S.A. Stereotactic interstitial irradiation of malignant brain tumors. Neurol Clin. 3:1985;883-893.
19. Halperin E.C., Burger P.C., Bullard D.E. The fallacy of the localized supratentorial malignant glioma. Int J Radiat Oncol Biol Phys. 15:1988;505-509.
20. Hochberg F.H., Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology. 30:1980;907-911.
21. Huber A., Beran H., Becherer A., Prosenc N., Witzmann A. Supratentorial glioma analysis of clinical and temporal parameters in 163 cases . Neurochirurgia. 36:1993;189-193.
22. Jelsma R., Bucy P.C. The treatment of glioblastoma multiforme of the brain. J Neurosurg. 27:1967;388-400.
23. Jelsma R., Bucy P.C. Glioblastoma multiforme. Its treatment and some factors affecting survival. Arch Neurol. 20:1969;161-171.
24. Jeremic B., Grujicic D., Antunovic V., Djuric L., Stojanovic M., Shibamoto Y. Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach. J Neurooncol. 21:1994;177-185.
25. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc. 53:1958;457-481.
26. Kelly P.J., Daumas-Duport C., Scheithauer B.W., Kall B.A., Kispert D.B. Stereotactic histologic correlations of computed tomography and magnetic resonance imaging defined abnormalities in patients with glial neoplasms. Mayo Clin Proc. 62:1987;450-459.
27. Kreth F.W., Warnke P.C., Scheremet R., Ostertag C.B. Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg. 78:1993;762-766.
28. Levin V.A., Hoffman W.F., Heilbron D.C., Norman D. Prognostic significance of the pretreatment CT scan on time to tumor progression for patients with malignant gliomas. J Neurosurg. 52:1980;642-647.
29. Nazzaro J.M., Neuwelt E.A. The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg. 73:1990;331-344.
30. Rostomily R.C., Spence A.M., Duong D., McCormick K., Bland M., Berger M.S. Multimodality management of recurrent adult malignant gliomas results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery . Neurosurgery. 35:1994;378-388.
31. Salcman M. Supratentorial gliomas clinical features and surgical therapy . Wilkins R.H. Neurosurgery. Vol. 1:1985;579-590 McGraw-Hill, New York.
32. Scanlon P.W., Taylor W.F. Radiotherapy of intracranial astrocytomas analysis of 417 cases treated from 1960 through 1969 . Neurosurgery. 5:1979;301-308.
33. Schag C.C., Heinrich R.L., Ganz P.A. Karnofsky performance status revisited reliability, validity, and guidelines . J Clin Oncol. 2:1984;187-193.
34. Shapiro W.R. Treatment of neuroectodermal brain tumors. Ann Neurol. 12:1982;231-237.
35. Tsuboi K., Yoshii Y., Nakagawa K., Maki Y. Regrowth patterns of supratentorial gliomas. Estimation from computed tomographic scans. Neurosurgery. 19:1986;946-951.
36. Walker M.D., Alexander E. Jr, Hunt W.E., MacCarty C.S., Mahaley M.S. Jr, Mealey J. Jr, Norrell H.A., Owens G., Ransohoff J., Wilson C.B., Gehan E.A., Strike T.A. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg. 49:1978;333-343.
37. Weir B. The relative significance of factors affecting postoperative survival in astrocytomas, grades 3 and 4. J Neurosurg. 38:1973;448-452.
38. Wood J.R., Green S.B., Shapiro W.R. The prognostic importance of tumor size in malignant gliomas a computed tomographic scan study by the Brain Tumor Cooperative Group . J Clin Oncol. 6:1988;338-343.
39. Yoshida J., Kajita Y., Wakabayashi T. Long-term follow-up results of 175 patients with malignant glioma importance of radical tumor resection and postoperative adjuvant therapy with interferon, ACNU and radiation . Acta Neurochir. 127:1994;55-59.